Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,211,769
in 7 filings, $50K under 10b5-1 plans

Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 46 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2014-04-14 McIntosh David M Director Shares withheld for taxes −99,010 $1.01 $100K 25,990
2014-04-14 McIntosh David M Director Exercise or conversion · Stock Options (right-to-buy) +125,000 0
2014-02-27 CARTHY MARK Director Grant or award · Stock Options (right to buy) +20,000 20,000
2014-01-12 Jeong Tae Heum Chief Financial Officer Grant or award · Stock Option (right to purchase) +175,000 175,000
2014-01-12 Ahn Chang Ho Director Grant or award · Stock Option (right to purchase) +125,000 125,000
2014-01-12 Soni Rakesh President and COO Grant or award · Stock Option (right to purchase) +85,000 85,000
2014-01-12 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +350,000 350,000
2013-09-09 Jeong Tae Heum Chief Financial Officer Exercise or conversion +150,000 $0.24 $36K 655,000
2013-09-09 Jeong Tae Heum Chief Financial Officer Shares withheld for taxes −78,861 $0.46 $36K 576,139
2013-09-09 Jeong Tae Heum Chief Financial Officer Sale −71,139 $0.46 $32K 505,000
2013-09-09 Jeong Tae Heum Chief Financial Officer Exercise or conversion · Stock Option (right to purchase) −150,000 0
2013-06-11 Beever Charles Director Grant or award · Stock Options (right-to-buy) +60,000 60,000
2013-06-11 McIntosh David M Director Grant or award · Stock Options (right-to-buy) +60,000 60,000
2013-06-11 Brandt Peter C. Director Grant or award · Stock Options (right-to-buy) +60,000 60,000
2013-06-11 Cheong Kwang Soo Director Grant or award · Stock Options (right-to-buy) +60,000 60,000
2013-06-11 Hwang Si Moon Director Grant or award · Stock Options (right-to-buy) +60,000 60,000
2013-03-01 Soni Rakesh President and COO Grant or award · Stock Option (right to purchase) +50,000 50,000
2013-03-01 Ahn Chang Ho Director Grant or award · Stock Option (right to purchase) +250,000 250,000
2013-03-01 Jeong Tae Heum Chief Financial Officer Grant or award · Stock Option (right to purchase) +250,000 250,000
2013-02-04 Suzdak Peter David Chief Executive Officer Grant or award · Stock Option (right to purchase) +1,200,000 1,200,000

Page 20 of 22 · 437 trades